Whalerock Point Partners’s Bristol-Myers Squibb BMY Stock Holding History

Whalerock Point Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$336K	Hold	5,534	–	–	0.06%	151
2025 Q4	$299K	Sell	5,534 -312	-5%	-$15K	0.06%	161
2025 Q3	$264K	Sell	5,846 -100	-2%	-$4.67K	0.05%	158
2025 Q2	$275K	Hold	5,946	–	–	0.06%	161
2025 Q1	$363K	Sell	5,946 -200	-3%	-$11.7K	0.09%	130
2024 Q4	$348K	Sell	6,146 -236	-4%	-$13.2K	0.08%	131
2024 Q3	$330K	Sell	6,382 -150	-2%	-$7.04K	0.08%	137
2024 Q2	$271K	Sell	6,532 -5,300	-45%	-$237K	0.07%	135
2024 Q1	$642K	Sell	11,832 -144	-1%	-$7.34K	0.18%	88
2023 Q4	$614K	Sell	11,976 -2,171	-15%	-$114K	0.19%	84
2023 Q3	$821K	Hold	14,147	–	–	0.28%	63
2023 Q2	$905K	Buy	14,147 +251	+2%	+$16.8K	0.31%	60
2023 Q1	$963K	Hold	13,896	–	–	0.36%	56
2022 Q4	$1,000K	Sell	13,896 -14	-0.1%	-$1.06K	0.41%	52
2022 Q3	$989K	Hold	13,910	–	–	0.43%	52
2022 Q2	$1.07M	Hold	13,910	–	–	0.45%	50
2022 Q1	$1.02M	Sell	13,910 -447	-3%	-$30K	0.36%	54
2021 Q4	$895K	Sell	14,357 -987	-6%	-$57.9K	0.31%	62
2021 Q3	$908K	Sell	15,344 -73	-0.5%	-$4.81K	0.35%	60
2021 Q2	$1.03M	Sell	15,417 -100	-0.6%	-$6.52K	0.4%	56
2021 Q1	$980K	Hold	15,517	–	–	0.43%	53
2020 Q4	$963K	Buy	15,517 +14,593	+1,579%	+$897K	0.46%	53
2020 Q3	$924K	Sell	924 -16,785	-95%	-$1.01M	0.51%	47
2020 Q2	$1.04M	Sell	17,709 -13,755	-44%	-$823K	0.61%	44
2020 Q1	$1.75M	Sell	31,464 -500	-2%	-$30.6K	1.25%	27
2019 Q4	$2.05M	Buy	31,964 +857	+3%	+$49.1K	1.09%	27
2019 Q3	$1.58M	Hold	31,107	–	–	0.85%	34
2019 Q2	$1.41M	Hold	31,107	–	–	0.81%	35
2019 Q1	$1.48M	Buy	31,107 +600	+2%	+$29.9K	0.97%	31
2018 Q4	$1.59M	Hold	30,507	–	–	1.48%	20
2018 Q3	$1.89M	Hold	30,507	–	–	1.37%	22
2018 Q2	$1.69M	Sell	30,507 -1,950	-6%	-$105K	1.35%	25
2018 Q1	$2.05M	Hold	32,457	–	–	0.66%	30
2017 Q4	$1.99M	Sell	32,457 -1,142	-3%	-$71.4K	0.63%	32
2017 Q3	$2.14M	Hold	33,599	–	–	0.76%	27
2017 Q2	$1.87M	Sell	33,599 -2,942	-8%	-$160K	0.69%	32
2017 Q1	$1.99M	Buy	36,541 +4,884	+15%	+$268K	0.74%	31
2016 Q4	$1.85M	Buy	31,657 +185	+0.6%	+$10.1K	0.73%	32
2016 Q3	$1.7M	Buy	+31,472	New	+$2.02M	0.7%	33
2016 Q1	$2M	Sell	31,322 -700	-2%	-$44.1K	0.86%	27
2015 Q4	$2.2M	Sell	32,022 -2,630	-8%	-$174K	0.96%	22
2015 Q3	$2.05M	Sell	34,652 -142	-0.4%	-$9.01K	0.88%	21
2015 Q2	$2.31M	Hold	34,794	–	–	0.96%	19
2015 Q1	$2.24M	Hold	34,794	–	–	0.91%	20
2014 Q4	$2.05M	Sell	34,794 -111	-0.3%	-$6.26K	0.87%	24
2014 Q3	$1.79M	Hold	34,905	–	–	0.81%	28
2014 Q2	$1.69M	Buy	34,905 +465	+1%	+$22.9K	0.8%	28
2014 Q1	$1.79M	Hold	34,440	–	–	0.91%	23
2013 Q4	$1.83M	Buy	+34,440	New	+$1.75M	0.96%	21

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Whalerock Point Partners's BMY Position: Q1 2026 in Review

Whalerock Point Partners held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 5,534 shares worth $336K. The position accounts for 0.06% of the portfolio, ranked #151.

Whalerock Point Partners first reported a position in BMY in Q4 2013 and has held it in 49 quarters since. The position peaked at $2.31M in Q2 2015. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Whalerock Point Partners held 5,534 shares of Bristol-Myers Squibb worth $336K as of Q1 2026.
Whalerock Point Partners left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up 0.06% of Whalerock Point Partners's portfolio in Q1 2026, its #151 holding.
Whalerock Point Partners first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 49 quarters since.
Whalerock Point Partners's Bristol-Myers Squibb position peaked at $2.31M in Q2 2015.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Whalerock Point Partners's 13F filing for Q1 2026, filed 15 May 2026.